Patent · US Active

Protease inhibitory antibodies and methods of use thereof

US11332546B2 · kind B2 · utility

0Cited by

2References

18Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Xin Ge · Riverside, US
Kibaek LEE · Houston, US

Key dates

Filing date	May 21, 2020
Grant date	May 17, 2022
Priority date	—
Expiry date	May 21, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Certain embodiments provide isolated anti-MMP-14 antibodies or fragments thereof, isolated anti-MMP-12 antibodies or fragments thereof, isolated anti-BACE-1 antibodies or fragments thereof, isolated anti-Alp2 antibodies or fragments thereof, and isolated anti-cathepsin B antibodies or fragments thereof, as well as methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.